Le Lézard
Classified in: Health, Science and technology
Subjects: AWD, CSR, ESG

Amgen Named To Dow Jones Sustainability World Index For Eighth Consecutive Year


THOUSAND OAKS, Calif., Nov. 29, 2021 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that it has been named to the Dow Jones Sustainability World Index for the eighth consecutive year, reflecting the company's enduring commitment to environmental, social, and governance (ESG) issues. Amgen also was named to the DJSI North America Index for the ninth straight year.

The DJSI Indices are among the best indicators of a company's ESG performance due to the breadth of companies evaluated ? nearly 11,000 this year ? and the rigorous nature of the annual assessment process. The DJSI World Index recognizes the top 10% of companies in the S&P Global Broad Market Index for performance on ESG issues, which S&P Global considers critical to generating long-term stakeholder value.

"Our mission is to serve patients and our ESG framework guides how we go about successfully accomplishing that mission," said Judy Brown, senior vice president, Corporate Affairs. "As we look to the future, we will continue to do our part to build a better, healthier world by addressing the challenges facing society that matter most to our business and to our stakeholders."

Amgen's four ESG pillars ? Healthy People, Healthy Society, Healthy Environment and a Healthy Amgen ? include commitments to:

"We congratulate Amgen for being included in the Dow Jones Sustainability Index for DJSI World and DJSI North America," said Manjit Jus, Global Head of ESG Research, S&P Global. "A DJSI distinction is a reflection of being a sustainability leader in your industry. The record number of companies participating in the 2021 S&P Global Corporate Sustainability Assessment is testament to the growing movement for ESG disclosure and transparency."

In May 2021, Amgen published a comprehensive Environmental, Social, and Governance Report, which is available here.

About Amgen

Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology.

Amgen focuses on areas of high unmet medical need and leverages its expertise to strive for solutions that improve health outcomes and dramatically improve people's lives. A biotechnology pioneer since 1980, Amgen has grown to be one of the world's leading independent biotechnology companies, has reached millions of patients around the world and is developing a pipeline of medicines with breakaway potential.

Amgen is one of the 30 companies that comprise the Dow Jones Industrial Average and is also part of the Nasdaq-100 index.  In 2021, Amgen was named one of the 25 World's Best Workplacestm by Fortune and Great Place to Worktm and one of the 100 most sustainable companies in the world by Barron's.

For more information, visit www.amgen.com and follow us on www.twitter.com/amgen.

CONTACT: Amgen, Thousand Oaks

Trish Rowland, 805-447-5631 (Media)
Megan Fox, 805-447-1423 (Media)
Arvind Sood, 805-447-1060 (Investors)

  1. Represents reductions against established baselines, taking into account only verified reduction projects, and does not take into account changes associated with contraction or expansion of the company.
  2. Amgen Foundation is a separate legal entity funded solely by Amgen.
  3. Amgen Safety Net Foundation is a separate legal entity entirely funded by Amgen.
  4. Valued at wholesale acquisition cost.

Amgen Logo. (PRNewsFoto/Amgen) (PRNewsFoto/)

SOURCE Amgen


These press releases may also interest you

at 15:30
The "Global Optical Emission Spectroscopy Market (2022-2027) by Offering, Form Factor, Detector Type, Excitation Source Type, End User, Competitive Analysis and the Impact of Covid-19 with Ansoff Analysis" report has been added to...

at 15:30
International Process Plants (IPP) announced its subsidiary Humber Industrials Ltd. has reached an agreement to purchase Novartis UK's 170-acre active pharmaceutical ingredient (API) manufacturing plant site and assets in Grimsby, UK....

at 15:20
First Coast Service Options, Inc., has been awarded the Jurisdiction N (JN) contract by the Centers for Medicare & Medicaid Services (CMS).  The contract covers Florida, and the U.S. Territories of Puerto Rico, and U.S. Virgin Islands. First Coast...

at 15:15
Second Genome, a biotechnology company that leverages its proprietary platform to discover and develop precision therapies and biomarkers, presented data demonstrating the Company's development candidate, SG-5-00455, improves epithelial barrier...

at 15:05
Denver-based NexCore Group, a national healthcare real estate (HRE) developer, today announced the hiring of seniors housing industry veteran, Jeff Slichta, as Chief Operating Officer of Experience Senior Living (ESL). Phill Barklow, ESL President,...

at 15:00
The Vision Impact Institute (VII) is pleased to join a partnership that brings eye care services to vulnerable populations in Panama. The partnership includes Lions Club Penonome, Panama, Universidad Especializada de las Americas (UDELAS) Panama, The...



News published on 29 november 2021 at 16:00 and distributed by: